Acambis Says Willing To Settle In Patent Fight

Law360, New York (September 13, 2006, 12:00 AM EDT) -- The head of Acambis said Wednesday the company would be willing to settle its patent dispute with Bavarian Nordic over a smallpox vaccine, but that he’s not optimistic the companies can come to an agreement.

Last week, an International Trade Commission administrative law judge ruled that Bavarian Nordic's patents for a smallpox vaccine are invalid, giving rival Acambis a leg up in a fight over millions of dollars in U.S. anti-terror funding.

"We have been open to settlement discussions from the beginning and were happy to...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.